Management of post laser in situ keratomileusis ectasia with simultaneous topography guided photorefractive keratectomy and collagen cross-linking.

Détails

Ressource 1Télécharger: 21399769_BIB_660B1563F951.pdf (1387.64 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_660B1563F951
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Management of post laser in situ keratomileusis ectasia with simultaneous topography guided photorefractive keratectomy and collagen cross-linking.
Périodique
The open ophthalmology journal
Auteur⸱e⸱s
Kymionis G.D., Portaliou D.M., Diakonis V.F., Karavitaki A.E., Panagopoulou S.I., Jankov Ii M.R., Coskunseven E.
ISSN
1874-3641 (Electronic)
ISSN-L
1874-3641
Statut éditorial
Publié
Date de publication
11/02/2011
Peer-reviewed
Oui
Volume
5
Pages
11-13
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
A thirty-nine year old man was referred to our institute due to progressive decreased visual acuity five years after bilateral Laser in situ Keratomileusis (LASIK). Topography revealed signs of post - LASIK ectasia. Patients' left eye was treated with simultaneous Topography Guided Photorefractive Keratectomy (PRK) followed by Corneal Collagen Cross Linking (CXL). Twelve months after the combined procedure both uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) showed significant improvement while topographic findings revealed an improvement of the astigmatic pattern. All higher order aberrations showed a significant decrease twelve months postoperatively. Combined topography guided PRK and corneal cross linking could represent an alternative treatment for post - LASIK ectasia.
Mots-clé
CXL., LASIK ectasia, Post, guided PRK, topography
Pubmed
Open Access
Oui
Création de la notice
01/10/2019 15:24
Dernière modification de la notice
15/01/2021 8:09
Données d'usage